Health Condition 1: M722- Plantar fascial fibromatosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age > 18 years and 2. Patients of plantar fascitis of atleast 6 weeks duration. 3. Patientâ??s pain refractory to primary conservative treatments (NRS >5). 4. Willingness to participate in the study and forgo any other concomitant treatment modality.
Exclusion criteria
Exclusion criteria: 1. Unwillingness to participate in the study. 2. Arthrosis or arthritis of foot, old-healed tendoachilles rupture. 3. History of foot trauma or Surgery. 4. History of injection in the involved foot during preceding 6 months. 5. Patients with history of vascular insufficiency, neuropathic heel pain, on anti-platelet or anticoagulant therapy, and on aspirin containing NSAIDS. 6. Any foot and ankle deformity including pes planus or pes cavus. 7. Pregnant and Breastfeeding females. 8. Uncontrolled psychiatric disorder or major depression or other severe medical illness. 9. Local infection or ongoing septicaemia. 10. Patients with autoimmune disease, malignancy, uncontrolled diabetes mellitus, hyperlipidemia and patients with BMI >30.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To determine the degree of pain relief in patients of Plantar Fascitis using Numerical rating scale(NRS)Timepoint: baseline, 1st week, 2nd week, 4th week and 6th week. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate the improvement in quality of life using foot health status questionnaire (FHSQ) at baseline and 6 weeks. 2. Requirement of rescue analgesics on weekly basis. 3. Any complication such as pain, bleeding, infection or any other complication occurring during and after the injection shall be noted. Timepoint: baseline, 1 week, 2 week, 4 week, 6 week | — |
Countries
India
Contacts
Jawahar Lal Nehru medical college and hospital, AMU Aligarh